Efficacy and tolerability of initial triple combination therapy with metformin, dapagliflozin and saxagliptin compared with stepwise add-on therapy in drug-naïve patients with type 2 diabetes (TRIPLE-AXEL study): A multicentre, randomized, 104-week, open-label, active-controlled trial
Kim NH, Moon JS, Lee YH, et al.
Diabetes Obes Metab. Pub. online 11 Jun 2024.
Leggi


